Detalles de la búsqueda
1.
Efficacy and safety of precision-guided transjugular extrahepatic portosystemic shunt (TEPS) in the management of cavernous transformation of the portal vein with portal hypertension: a case series.
Hepatol Int
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594475
2.
[Study on clinical features and etiology of primary Budd-Chiari Syndrome].
Zhonghua Gan Zang Bing Za Zhi
; 21(11): 850-4, 2013 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-24331696
3.
Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
World J Gastroenterol
; 29(18): 2875-2887, 2023 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37274064
4.
Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation.
Drug Des Devel Ther
; 16: 3421-3429, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203820
5.
Novel roles of lipopolysaccharide and TLR4/NF-κB signaling pathway in inflammatory response to liver injury in Budd-Chiari syndrome.
World J Gastrointest Surg
; 13(11): 1448-1462, 2021 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950433
6.
Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.
World J Gastroenterol
; 26(24): 3472-3483, 2020 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32655270
7.
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma.
Drug Des Devel Ther
; 14: 3461-3468, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32904650
8.
FLT3/FLT3L-mediated CD103+ dendritic cells alleviates hepatic ischemia-reperfusion injury in mice via activation of treg cells.
Biomed Pharmacother
; 118: 109031, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31545219
9.
Interventional Treatment Strategy for Primary Budd-Chiari Syndrome with Both Inferior Vena Cava and Hepatic Vein Involvement: Patients from Two Centers in China.
Cardiovasc Intervent Radiol
; 42(9): 1311-1321, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31218407
10.
Outcomes of endovascular interventional therapy for primary Budd-Chiari syndrome caused by hepatic venous obstruction.
Exp Ther Med
; 16(5): 4141-4149, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30402156
11.
Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model.
Exp Ther Med
; 16(6): 5227-5235, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30542478
12.
Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis.
Cancer Manag Res
; 10: 4719-4726, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30410405
13.
The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer.
Medicine (Baltimore)
; 96(52): e9535, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29384971
14.
Liver Abscess Formation Following Transarterial Chemoembolization: Clinical Features, Risk Factors, Bacteria Spectrum, and Percutaneous Catheter Drainage.
Medicine (Baltimore)
; 95(17): e3503, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27124055
15.
The Significance of Serum CA-125 Elevation in Chinese Patients with Primary Budd-Chiari Syndrome: A Multicenter Study.
Gastroenterol Res Pract
; 2015: 121060, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26451141
16.
CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal Cancers.
Korean J Radiol
; 16(4): 810-20, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26175580
17.
Imaging features of primary hepatic leiomyosarcoma: A case report and review of literature.
Oncol Lett
; 9(5): 2256-2260, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137052
Resultados
1 -
17
de 17
1
Próxima >
>>